Skip to main content

CS DIAGNOSTICS CORP.

corporate_fare Company Profile

CS DIAGNOSTICS CORP.

CSDX·OTC·Industrial Applications And Services·CIK 0001106861

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.

CS DIAGNOSTICS CORP. (OTC:CSDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 3 items for CSDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-23, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 10/10, with 3 rated 8 or above. Recent SEC coverage for CSDX spans 8-K, 10-K, 10-12G/A.

Recent high-impact activity:

  • CS Diagnostics Declares Non-Reliance on Past Financials, to Restate Due to $499M Intangible Asset Error
  • Auditor Flags Going Concern, Material Weakness in Controls Amidst Dire Cash Position
  • CS Diagnostics Corp. Restates Financials, Removes $499M Asset Amidst Critical Liquidity and Going Concern Doubts

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,352 shares in CSDX as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.

Short interest (bi-monthly positions)1,352 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover1.00 at avg daily volume of 5,204

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.0698
52-week range · as of 2026-06-23 $0.036 – $0.40
Market cap
$17.45M
Volume
300 (0.0× avg)
3-mo avg 30.9K
Live data · 2026-11-22 12:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CSDX - Latest Insights

CSDX
Jun 23, 2026, 10:34 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.039
Real-time Price: $0.0698 info
Change: Low Volume info
Market Cap: $17.449M info
CSDX
Apr 15, 2026, 3:54 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.130
Real-time Price: $0.0698 info
Change: Low Volume info
Market Cap: $17.449M info
CSDX
Mar 12, 2026, 12:05 PM EDT
Filing Type: 10-12G/A
Importance Score:
10
Price at Filing: $0.2019
Real-time Price: $0.0698 info
Change: Low Volume info
Market Cap: $17.449M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets